JT Stratford LLC’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $846K | Sell |
7,035
-3,877
| -36% | -$448K | 0.11% | 168 |
|
|
2025
Q4 | $1.15M | Sell |
10,912
-2,102
| -16% | -$197K | 0.15% | 138 |
|
|
2025
Q3 | $1.09M | Sell |
13,014
-4,601
| -26% | -$379K | 0.15% | 139 |
|
|
2025
Q2 | $1.39M | Sell |
17,615
-1,043
| -6% | -$82.9K | 0.21% | 109 |
|
|
2025
Q1 | $1.67M | Buy |
18,658
+12,268
| +192% | +$1.15M | 0.3% | 83 |
|
|
2024
Q4 | $636K | Sell |
6,390
-50
| -0.8% | -$5.16K | 0.1% | 179 |
|
|
2024
Q3 | $731K | Buy |
6,440
+557
| +9% | +$66.2K | 0.13% | 164 |
|
|
2024
Q2 | $728K | Sell |
5,883
-154
| -3% | -$19.8K | 0.14% | 156 |
|
|
2024
Q1 | $797K | Sell |
6,037
-298
| -5% | -$36.7K | 0.16% | 154 |
|
|
2023
Q4 | $691K | Buy |
6,335
+115
| +2% | +$11.9K | 0.16% | 151 |
|
|
2023
Q3 | $640K | Sell |
6,220
-5,803
| -48% | -$625K | 0.17% | 144 |
|
|
2023
Q2 | $1.39M | Buy |
12,023
+5,901
| +96% | +$670K | 0.37% | 75 |
|
|
2023
Q1 | $651K | Sell |
6,122
-1,558
| -20% | -$168K | 0.19% | 120 |
|
|
2022
Q4 | $852K | Buy |
7,680
+3,045
| +66% | +$311K | 0.27% | 101 |
|
|
2022
Q3 | $399K | Sell |
4,635
-157
| -3% | -$14K | 0.14% | 126 |
|
|
2022
Q2 | $437K | Sell |
4,792
-177
| -4% | -$15.7K | 0.14% | 131 |
|
|
2022
Q1 | $408K | Sell |
4,969
-1,161
| -19% | -$91.5K | 0.12% | 142 |
|
|
2021
Q4 | $470K | Buy |
6,130
+243
| +4% | +$19.4K | 0.13% | 143 |
|
|
2021
Q3 | $442K | Sell |
5,887
-89
| -1% | -$6.77K | 0.14% | 132 |
|
|
2021
Q2 | $465K | Sell |
5,976
-259
| -4% | -$19.3K | 0.15% | 128 |
|
|
2021
Q1 | $459K | Sell |
6,235
-541
| -8% | -$39.9K | 0.16% | 123 |
|
|
2020
Q4 | $529K | Buy |
6,776
+422
| +7% | +$32.3K | 0.2% | 97 |
|
|
2020
Q3 | $503K | Sell |
6,354
-2,873
| -31% | -$225K | 0.22% | 92 |
|
|
2020
Q2 | $681K | Buy |
9,227
+2,686
| +41% | +$202K | 0.35% | 78 |
|
|
2020
Q1 | $480K | Sell |
6,541
-1,768
| -21% | -$139K | 0.29% | 69 |
|
|
2019
Q4 | $721K | Sell |
8,309
-2,323
| -22% | -$191K | 0.33% | 78 |
|
|
2019
Q3 | $854K | Buy |
10,632
+1,759
| +20% | +$141K | 0.48% | 64 |
|
|
2019
Q2 | $710K | Sell |
8,873
-24,010
| -73% | -$1.84M | 0.39% | 67 |
|
|
2019
Q1 | $2.61M | Sell |
32,883
-8,267
| -20% | -$618K | 1.5% | 16 |
|
|
2018
Q4 | $3M | Sell |
41,150
-2,557
| -6% | -$181K | 2% | 11 |
|
|
2018
Q3 | $2.96M | Sell |
43,707
-624
| -1% | -$39.8K | 1.7% | 17 |
|
|
2018
Q2 | $2.57M | Buy |
44,331
+24
| +0.1% | +$1.35K | 1.58% | 22 |
|
|
2018
Q1 | $2.3M | Buy |
44,307
+4,785
| +12% | +$258K | 1.44% | 27 |
|
|
2017
Q4 | $2.12M | Sell |
39,522
-4,545
| -10% | -$252K | 1.38% | 29 |
|
|
2017
Q3 | $2.69M | Sell |
44,067
-1,397
| -3% | -$84.7K | 1.74% | 17 |
|
|
2017
Q2 | $2.78M | Buy |
45,464
+1,729
| +4% | +$105K | 1.96% | 9 |
|
|
2017
Q1 | $2.65M | Buy |
43,735
+1,119
| +3% | +$67.9K | 1.97% | 14 |
|
|
2016
Q4 | $2.39M | Buy |
+42,616
| New | +$2.49M | 2.01% | 12 |
|
Other funds holding MRK
VCM
VPM
JT Stratford LLC's MRK Position: Q1 2026 in Review
JT Stratford LLC reduced its Merck (MRK) stake by 36% in Q1 2026, selling an estimated $448K and leaving 7,035 shares worth $846K. The position accounts for 0.11% of the portfolio, ranked #168.
JT Stratford LLC first reported a position in MRK in Q4 2016 and has held it in 38 quarters since. The position peaked at $3M in Q4 2018. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- JT Stratford LLC held 7,035 shares of Merck worth $846K as of Q1 2026.
- JT Stratford LLC sold 3,877 Merck shares in Q1 2026, an estimated $448K.
- Merck made up 0.11% of JT Stratford LLC's portfolio in Q1 2026, its #168 holding.
- JT Stratford LLC first reported a position in Merck in Q4 2016 and has held it in 38 quarters since.
- JT Stratford LLC's Merck position peaked at $3M in Q4 2018.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on JT Stratford LLC's 13F filing for Q1 2026, filed 15 May 2026.